Navigation Links
Removing Medical Device Preemption Impacts Jobs, Health Care Costs, Patient Access
Date:5/6/2009

BOSTON, May 6 /PRNewswire-USNewswire/ -- In a white paper released today by Ernst Berndt and Mark Trusheim of the Massachusetts Institute of Technology, research shows that eliminating FDA's preemption protection would decrease patients' access to life-enhancing medical devices, increase health care costs and reduce medical device industry employment.

The paper, "The Economic Impact of Eliminating Federal Preemption for Medical Devices on Patients, Innovation and Jobs," comes as Congress considers legislation that would remove Federal preemption of state rules and litigation that exists for a small percentage of medical devices that undergoes the most rigorous FDA review. The report highlights the damaging economic, health and societal impacts the legislation would have on patients, medical device industry innovation and employees, and the public health.

"As economic and health care researchers, we felt it was important to examine how this regulatory change could harm innovation, and ultimately impact the patients who rely on these treatments and the people who are employed by the device industry" said co-author Ernst Berndt, Ph.D., Louis E. Seley Professor in Applied Economics, MIT Sloan School of Management. "Congress should carefully weigh any policies that could increase health care costs and reduce high-paying jobs, particularly during an economic downturn."

The authors' research highlights the consequences to multiple stakeholders - patients and the public health, medical device inventors and manufacturers, their employees and the government - if medical device preemption were eliminated. For example,

  • Patients' access to medical devices and the benefits they provide would be reduced; as prices increase, products may be withdrawn, and fewer new products will be developed.
  • Physicians will i
    '/>"/>

SOURCE Berndt Associates
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. National Multiple Sclerosis Society Commends President Obamas Initial Steps in Removing the Bans on Embryonic Stem Cell Research
2. Remedy for Cracked Heels and Removing Calluses
3. Indoor Allergy Week - Cleanaer™, the New Air Purifier that Helps Prevent Spread of the Common Cold While Removing Airborne Allergen
4. Wal-Mart & Nalgene Removing Toxic Bottles, Place Consumers Concerns First
5. Removing Ovaries Before Menopause Leads to Memory, Movement Troubles
6. Medical University of South Carolina Automates Grants Allocation Process with Lombardi Business Process Management Software
7. Symmetry Medical to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
8. Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
9. New Jersey IT Services Firm to Host Educational Luncheon Event, EMR & Information Technology for the Specialty Medical Practice
10. For Medical Device Makers, Full Spectrum Software Releases Software Technology Report Called How to Survive in 2009 and Beyond
11. Local Medical Association Opposes Two State Propositions
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5NMB 26apos 3Bs New Series of Standard Hybrid Stepper Motors Now Available 54875 1NMB 26apos 3Bs New Series of Standard Hybrid Stepper Motors Now Available 54875 2National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 1National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 2National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 3Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 1Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 2Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 3Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 4